高级检索
当前位置: 首页 > 详情页

MiR-4268 suppresses gastric cancer genesis through inhibiting keratin 80

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Wuhan Univ Sci & Technol, Dept Gastroenterol, Puren Hosp, Wuhan, Hubei, Peoples R China [2]Wuhan Univ, Wuhan Hosp 3, Dept Radiol, Tongren Hosp, Wuhan, Hubei, Peoples R China [3]Third Peoples Hosp Hubei Prov, Dept Gastroenterol, Wuhan, Hubei, Peoples R China [4]Wuhan Univ, Wuhan Hosp 3, Dept Gastroenterol, Tongren Hosp,Opt Valley Area, 216 Guanshan Ave, Wuhan 430060, Hubei, Peoples R China
出处:
ISSN:

关键词: Gastric cancer miR-4268 KRT80 proliferation apoptosis

摘要:
Gastric cancer (GC) affects a large proportion of cancer patients worldwide, and the prediction of potential biomarkers can greatly improve its diagnosis and treatment. Here, miR-4268 and keratin 80 (KRT80) expression in GC tissues and cell lines was determined. The effect of downregulating miR-4268 and interfering with KRT80 expression on the viability, proliferation, apoptosis, and migration of GC cells were evaluated. The interaction between miR-4268 and KRT80 was studied using luciferase reporter and RNA pull-down assays. The western blot, CCK-8, BrdU, caspase-3 activity, Transwell assays were performed for the functional characterization. In GC tissues and cells, KRT80 expression was found to be significantly higher, while that of miR-4268 was significantly lower than the respective expressions in normal tissues and cells. Interference with KRT80 expression inhibited the viability, proliferation, and migration of GC cells and facilitated cell apoptosis in vitro. We further demonstrated that miR-4268 targeted KRT80 and negatively regulated its expression, and miR-4268 inhibitor alleviated the inhibitory effects of KRT80 downregulation on GC cell growth. Finally, miR-4268 may function as tumor suppressor through inhibiting PI3K/AKT/JNK pathways by targeting KRT80 in GC. Collectively, our present results indicate that the miR-4268/KRT80 axis acts as a potential therapeutic target for patients with GC.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 3 区 生物学
小类 | 4 区 细胞生物学
最新[2025]版:
大类 | 3 区 生物学
小类 | 4 区 细胞生物学
JCR分区:
出版当年[2020]版:
Q2 CELL BIOLOGY
最新[2023]版:
Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Wuhan Univ Sci & Technol, Dept Gastroenterol, Puren Hosp, Wuhan, Hubei, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [4]Wuhan Univ, Wuhan Hosp 3, Dept Gastroenterol, Tongren Hosp,Opt Valley Area, 216 Guanshan Ave, Wuhan 430060, Hubei, Peoples R China [*1]Department of Gastroenterology, Wuhan Third Hospital, Tongren Hospital of Wuhan University (Optics Valley Area), No. 216 Guanshan Avenue, Hongshan District, Wuhan 430060, Hubei, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:25471 今日访问量:0 总访问量:1498 更新日期:2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)